Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Public ClinicalTrials.gov record NCT05135286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Double-Masked, Randomized, Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF Topical Ophthalmic Solution With Emmetropic Phakic and Pseudophakic Presbyopia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Study identification
- NCT ID
- NCT05135286
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 629 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2022 (Actual)
- Primary completion
- Mar 13, 2025 (Actual)
- Completion
- Mar 13, 2025 (Actual)
- Last update posted
- Aug 6, 2025
2022 – 2025
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Visus Therapeutics Investigative Site | Chandler | Arizona | 85224 | — |
| Visus Therapeutics Investigative Site | Phoenix | Arizona | 85032 | — |
| Visus Therapeutics Investigative Site | Sun City | Arizona | 85351 | — |
| Visus Therapeutics Investigative Site | Glendale | California | 91204 | — |
| Visus Therapeutics Investigative Site | Inglewood | California | 90301 | — |
| Visus Therapeutics Investigative Site | Irvine | California | 92604 | — |
| Visus Therapeutics Investigative Site | Mission Hills | California | 91345 | — |
| Visus Therapeutics Investigative Site | Newport Beach | California | 92663 | — |
| Visus Therapeutics Investigative Site | Pasadena | California | 91107 | — |
| Visus Therapeutics Investigative Site | Santa Barbara | California | 93105 | — |
| Visus Therapeutics Investigative Site | Littleton | Colorado | 80120 | — |
| Visus Therapeutics Investigative Site | Danbury | Connecticut | 06810 | — |
| Visus Therapeutics Investigative Site | Crystal River | Florida | 34429 | — |
| Visus Therapeutics Investigative Site | Delray Beach | Florida | 33484 | — |
| Visus Therapeutics Investigative Site | Fort Lauderdale | Florida | 33309 | — |
| Visus Therapeutics Investigative Site | Jacksonville | Florida | 32256 | — |
| Visus Therapeutics Investigative Site | Largo | Florida | 33770 | — |
| Visus Therapeutics Investigative Site | Mt. Dora | Florida | 32757 | — |
| Visus Therapeutics Investigative Site | Lake Villa | Illinois | 60046 | — |
| Visus Therapeutics Investigative Site | Indianapolis | Indiana | 46260 | — |
| Visus Therapeutics Investigative Site | Louisville | Kentucky | 40206 | — |
| Visus Therapeutics Investigative Site | Bloomington | Minnesota | 55420 | — |
| Visus Therapeutics Investigative Site | Kansas City | Missouri | 64111 | — |
| Visus Therapeutics Investigative Site | St Louis | Missouri | 63128 | — |
| Visus Therapeutics Investigative Site | Henderson | Nevada | 89502 | — |
| Visus Therapeutics Investigative Site | Poughkeepsie | New York | 12603 | — |
| Visus Therapeutics Investigative Site | Garner | North Carolina | 27529 | — |
| Visus Therapeutics Investigative Site | West Fargo | North Dakota | 58078 | — |
| Visus Therapeutics Investigative Site | Powell | Ohio | 43065 | — |
| Visus Therapeutics Investigative Site | Portland | Oregon | 97210 | — |
| Visus Therapeutics Investigative Site | Cranberry Township | Pennsylvania | 16066 | — |
| Visus Therapeutics Investigative Site | Wilkes-Barre | Pennsylvania | 18702 | — |
| Visus Therapeutics Investigative Site | Sioux Falls | South Dakota | 57108 | — |
| Visus Therapeutics Investigative Site | Maryville | Tennessee | 37803 | — |
| Visus Therapeutics Investigative Site | Memphis | Tennessee | 38119 | — |
| Visus Therapeutics Investigative Site | Smyrna | Tennessee | 37167 | — |
| Visus Therapeutics Investigative Site | Hurst | Texas | 76054 | — |
| Visus Therapeutics Investigative Site | Lakeway | Texas | 78738 | — |
| Visus Therapeutics Investigative Site | San Antonio | Texas | 78229 | — |
| Visus Therapeutics Investigative Site | Draper | Utah | 84020 | — |
| Visus Therapeutics Investigative Site | Falls Church | Virginia | 22046 | — |
| Visus Therapeutics Investigative Site | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05135286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05135286 live on ClinicalTrials.gov.